Use of Implicit Criteria to Determine Appropriateness of Medication in Geriatric Populations Brittany Barnes Pharm.D Candidate 2013, Marilyn N. Bulloch,

Slides:



Advertisements
Similar presentations
UGA Doctor of Pharmacy Candidate
Advertisements

Medication Management
Conducting the Community Analysis. What is a Community Analysis?  Includes market research and broader analysis of community assets and challenges 
Improving Dementia Care and Reducing Unnecessary Use of Antipsychotic Medications in Nursing Homes Alice Bonner, PhD, RN Division of Nursing Homes Center.
Table 1: Top five examples of PIP according to the STOPP criteria
MARIJUANA AT THE END OF LIFE: ONE FOR THE ROAD? Mary Lynn McPherson, Pharm.D., BCPS, CPE Professor and Vice Chair University of Maryland School of Pharmacy.
Medication Regimen Review Guidance Training CFR § (c)(1)(2) F428.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Potentially inappropriate prescribing and.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
BACKGROUND & OBJECTIVES Approximately 1 in 20 U.S. adults age 50 and over have depression 1 More than half of these older adults have depression with severe.
Clinical Pharmacist Intervention in Cardiac Patients With Renal Impairment Elham Al-Shammari, B.Sc. Pharm. Hisham Abou-Auda, Ph. D. Meshal Al-Mutairi,
1 Alvimopan RiskMAP Joyce Weaver, Pharm.D., BCPS Office of Surveillance and Epidemiology.
…patient reported outcome (PRO) measure for your clinical study Dr Keith Meadows, DHP Research & Consultancy Ltd.
Pharmacology in the Elderly. Pharmacological Challenges in the Elderly  Pharmacokinetic changes  Pharmacodynamic changes  Multiple co-morbidities 
Clinical Pharmacy Basma Y. Kentab MSc..
Critical Appraisal of Clinical Practice Guidelines
Drug safety in the elderly EFNS Stockholm 2012 Barbro Westerholm Prof.em, Member of Swedish Parliament.
Unit 6b: Clinical Decision Support Systems that Help Improve Quality Decision Support for Quality Improvement This material was developed by Johns Hopkins.
Unit 6.2: Clinical Decision Support Systems that Help Improve Quality Decision Support for Quality Improvement Component 12/Unit 6.21Health IT Workforce.
Centralized Non-Formulary Processing: Implementation of a CPRS “Reminder Dialog Template” Note to Request Restricted Drugs and Utilization of VISN 17 PBM.
CPRS/Pharmacy Laboratory Monitoring Project
1 Prescribing Omissions according to START and related hospital admission in geriatric patients O. Dalleur 1, A. Spinewine 2, S. Henrard 3, C. Losseau.
The impact of a pharmacy student led discussion group on parents of teenagers living with cancer: a service-based learning project Rachel Saroka and Amy.
Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support health professionals caring for people living with MCC.
Interdisciplinary Teamwork in a Transitional Primary Care Clinic Tamara Malm, PharmD, MPH, BCPS September 18, 2015.
Clinical Pharmacy Part 2
Problems of Polypharmacy
Compliance with clinical practice guidelines for the treatment and optimization of therapy in heart failure patients in outpatient medicine clinics MaryAnn.
Evaluation of intravenous acetaminophen use in a large community hospital Andrew R. Mameli, Pharm.D. Candidate, Nicholas L. Massie, Pharm.D., Richard L.
Evaluating clinical pharmacist impact on diabetes control: outcomes on hemoglobin A1c Mark Amoo PharmD Candidate, Dalton Walsh PharmD Candidate, Kalyani.
Measuring and Evaluating Indicators of Appropriate Prescribing in Older Populations Cahir C., Teeling M., Teljeur C., Bennett K., Fahey T. HRB PhD Scholar.
17 tools identified composed mostly of (>95%) explicit criteria 4 versions of the Beers Criteria were found The original Beers Criteria (1991) or subsequent.
The Impact of a Simulation-Based Exercise on Knowledge Retention and Confidence Regarding Medication Use and Preparation for Medical Emergencies Marilyn.
* Indicates p < 0.05 indicates p < 0.05 Evaluating Clinical Pharmacist Impact on Diabetes Control* Mary Ella Hill, Pharm. D. Candidate; Orijane Dalton,
Polypharmacy May 2008 CRIT Heidi Auerbach, MD Copyright Boston University Medical Center.
To evaluate the availability of medication studies enrolling patients that are 80 years of age and older. Evaluation of Medication Studies Enrolling Patients.
June 24, 2003 Health Communications Progress Review Focus Area 11.
Comparison of two cardiovascular risk assessment tools to determine appropriate use of aspirin as primary prevention for patients with type 2 diabetes.
Appraisal of Guidelines for Research & Evaluation Using the AGREE¹ Instrument CAN-IMPLEMENT Toolkit Version 1.0 April 2010 Modified from:
Outcomes of Individualized Formative Assessments in the Pharmacy Skills Laboratory Tyler H. Gums, Pharm.D. & Erika L. Kleppinger, Pharm.D., BCPS, CDE Auburn.
ASSESSING THE FEASIBILITY OF ANTIBIOTIC MANAGEMENT SERVICES THROUGH PROSPECTIVE EVALUATION ABSTRACT PURPOSE: The inappropriate and unnecessary use of antibiotics.
Introduction.
Optimization of psychotropic drug prescription in nursing home patients with dementia: the PROPER study (PRescription Optimization of Psychotropic drugs.
EBM --- Journal Reading Presenter :呂宥達 Date : 2005/10/27.
Pharmacotherapy in older age. Changes in pharmacokinetics and pharmacodynamics Polymorbidity, risk of DRUG-DISEASE interactions Polypharmacy, risk of.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Terry McInnis, MD MPH President- Blue Thorn, Inc - Mobile Co-Chair- Center for.
Medicines management in the elderly Trudi McIntosh and Kim Munro School of Pharmacy and Life Sciences RGU.
Medication Management in the Older Patient. Older adults are more likely to have an Adverse Drug Reaction More likely to be on 5 or more medications Hazzard,
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
EVALUATING THE EFFECTIVENESS OF THE AGS UPDATED 2012 BEERS CRITERIA AS AN EDUCATIONAL TOOL IN A FAMILY MEDICINE RESIDENCY TRAINING PROGRAM Eseoghene Abokede.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Using an EHR Template and the Beer’s List to Address Geriatric Polypharmacy Rose Family Medicine Residency Emily Gutgsell, MD Emma Bjore, MD Anna Plunkett,
Prescribing for the Oldest Old
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
Community Hospital Pharmacy Practice January 29, 2004
POLYPHARMACY IN GERIATRIC PATIENTS Dr SHREYAS MISTRY MD, Dr MAYUR RALI MD HOFSTRA-North Shore LIJ School of Medicine Department of Family Medicine Southside.
Intergenerational Programs’ Effect on the Mental Health of the Elderly
@Improve_Academy #WeStopMeds.
Drug Information Resources
Polypharmacy In Adults: Small Test of Change
Does the Beer’s Criteria Influence Prescribing for Geriatric Patients?
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Evidence-based Medicine Curriculum
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Pharmacy practice experience I
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Presentation transcript:

Use of Implicit Criteria to Determine Appropriateness of Medication in Geriatric Populations Brittany Barnes Pharm.D Candidate 2013, Marilyn N. Bulloch, Pharm. D, BCPS Introduction In 2010, the U.S. Census Bureau reported that people older than the age of 65 made up thirteen percent of the total population. Though this is not the largest segment of the population, it had the second largest increase from 2000 to In addition to this rapid increase in population, the segment aged 80 and older is the fastest growing population. The projected life expectancy for the total population for the year 2015 and 2020 is 78.9 and 79.5 years respectively. With the rise in the number of geriatric patients ever increasing, a heightened focus on suboptimal medication use is emerging. Due to multiple chronic comorbidities the geriatric populations face, they have the highest number of prescriptions per person than any other age group. Higher numbers of prescriptions and prescribers leads to polypharmacy. Polypharmacy is a state where a patient is taking more medications that what is warranted, and this can expose a patient to unnecessary adverse events, harmful drug interactions, and overmedication or undermedication. The effects of polypharmacy intesify in the geriatric populationdue to age-related changes in pharmacokinetics and pharmacodynamics which causes drugs to stay in the body longer or strengthen the effects of medications. To overcome this problem, tools containing explicit and implicit criteria have been developed to avoid potentially harmful or unnecessary medications. Both types of tools were developed using evidence-based medicine. Explicit criteria are lists complied by geriatric experts of medications to avoid, where as implicit criteria guide the user to determine appropriateness based on their own clinical judgment on a patient specific basis. There are several types of implicit tools available and the content and method varies from each defined criteria. This study gives an overview of the different implicit criteria that are available for determining appropriateness of medications in elderly populations. Results Purpose Search of PubMed, MEDLINE, and Google Scholar Keywords searched: implicit, criteria, geriatric, prescribing, inappropriate, polypharmacy, medication Original studies, reviews, systemic-reviews, and commentary reviewed Inclusion criteria: studies involving patients 65 and older, English language Thirty five articles were reviewed and from this sixteen implicit tools included in this study Conclusion Disclosure: Authors of this presentation have the following to disclose concerning possible financial or personal relationships with commercial entities that may have a direct or indirect interest in the subject matter of this presentation Brittany Barnes: Nothing to disclose Marilyn Bulloch: Nothing to disclose References are available on request. Methods The purpose of this study was to evaluate and compare currently available implicit tools used for for the evaluation of appropriateness of medication in elderly populations (65 or older). Implicit CriteriaDesign Medication Appropriateness Index 10 criteria; each criteria linked to a weighted value to provide a score (0-18) per drug ≥10 minutes per medication Fitted for the Aged (FORTA) Grading system of medication (A- D) similar to the pregnancy category grading system Assessment time not reported Lipton’s Criteria6 criteria assigned a rating of 1,2 or 9 to determine the appropriateness of medicine Assessment time ~15 minutes; unknown if per drug or patient Assessment of Underutilization of Medication (AOU) Compares list of chronic medical conditions to list of prescribed drugs; a rating of no omission, marginal omission, or omission assigned Assessment time not reported Good Palliative- Geriatric Practice Algorithm used to determine the possibility of discontinuation of medications Assessment time not reported Criteria to Assess Appropriate Medication Use Interprets current guidelines for chronic medical conditions for patients with the pre- specified conditions Tool to Improve Medications in Elderly via Review (TIMER) Guide for pharmacist and pharmacy student when performing a medication review 4 sections using a scale ranging from strongly agree to strongly disagree Time consuming; training required Assess, Review, Minimize, Optimize, Reassess (ARMOR) Interactive tool that takes into account clinical profile and functional status Goals improvement in functional status and mobility Assessment time not reported Prescribing Optimization Method (POM) 6 open-ended questions that aid in optimizing prescribing therapy in older patients Each question associated with potential follow-up issues Time consuming; education for prescriber is recommended Anticholinergic Risk Scale (ARS) List of medications with anticholinergic potential, each given a numerical value 1,2, or 3 Total score calculated by adding the points for each drug Assessment time not reported Geriatric Medicine Algorithm Algorithm; 6 criteria are evaluated Explicit list of high risk and dose adjustment drugs are provided Assessment time not reported; author reports time demand not unreasonable Drug Burden Index (DBI) Formula used to describe anticholinergic and sedative burden Total score calculated from combination of anticholinergic and /or sedative properties and total medication number May be time consuming; scores provide by consultant Time Until BenefitModel that guides users in discontinuation of therapies Remaining life expectancy, time until benefit, goals of care, and target therapy are evaluated Assessment time not reported Minimum Data Set 2.0 (MDS) Component of the Resident Assessment Instrument (RAI) 15 sections composed of 3-9 questions; areas in red trigger Resident Assessment Protocol (RAP) Assessment time: 1-2 hours Pharmacist’s Management of Drug Related Problems A step-by-step process of 9 functions for pharmacist to evaluate medication regimens Assessment time not reported; training required Oborne et al.14 indicators to evaluate the appropriateness of prescribed medications Algorithms for ACE-Inhibitors, Benzodiazepines, digoxin, B2-agonist Assessment time not reported 16 implicit tools have been developed to evaluate the appropriateness of medications in geriatric patients There are numerous implicit criteria models and each is different in areas of design, content, and clinical application Time of assessment ranged from ten minutes per drug to one to two hours which may be a disadvantage Implicit criteria can aid in the reduction of suboptimal prescribing in geriatric patients by assessing given information on a patient specific basis